Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 691

1.

Multidisciplinary pain management program for patients with chronic musculoskeletal pain in Japan: a cohort study.

Takahashi N, Takatsuki K, Kasahara S, Yabuki S.

J Pain Res. 2019 Aug 21;12:2563-2576. doi: 10.2147/JPR.S212205. eCollection 2019.

2.

Delay in the Provision of Medication by a Pharmacy Outside the Respiratory Outpatient Department.

Matsumoto M, Fujita S, Kannen M, Kawase K, Kaneshiro K, Takatsuki K.

Yakugaku Zasshi. 2017 Mar 1;137(3):355-361. doi: 10.1248/yakushi.16-00212. Epub 2016 Dec 5. Japanese.

3.

Liquid Chromatography Chip with Low-Dispersion and Low-Pressure-Drop Turn Structure Utilizing a Distribution-Controlled Pillar Array.

Isokawa M, Takatsuki K, Song Y, Shih K, Nakanishi K, Xie Z, Yoon DH, Sekiguchi T, Funatsu T, Shoji S, Tsunoda M.

Anal Chem. 2016 Jun 21;88(12):6485-91. doi: 10.1021/acs.analchem.6b01201. Epub 2016 Jun 8.

PMID:
27276442
4.

Rapid quantitative method for the detection of phenylalanine and tyrosine in human plasma using pillar array columns and gradient elution.

Song Y, Takatsuki K, Sekiguchi T, Funatsu T, Shoji S, Tsunoda M.

Amino Acids. 2016 Jul;48(7):1731-5. doi: 10.1007/s00726-016-2248-6. Epub 2016 May 21.

PMID:
27209196
5.

[A HEALTHY ADULT WITH DISSEMINATED NONTUBERCULOUS MYCOBACTERIAL INFECTION WITH MULTIPLE BONE LESIONS].

Kaneshiro K, Takatsuki K, Kanamori K.

Kekkaku. 2015 Apr;90(4):457-61. Japanese.

PMID:
26489148
6.

LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistance.

Lan F, Misu H, Chikamoto K, Takayama H, Kikuchi A, Mohri K, Takata N, Hayashi H, Matsuzawa-Nagata N, Takeshita Y, Noda H, Matsumoto Y, Ota T, Nagano T, Nakagen M, Miyamoto K, Takatsuki K, Seo T, Iwayama K, Tokuyama K, Matsugo S, Tang H, Saito Y, Yamagoe S, Kaneko S, Takamura T.

Diabetes. 2014 May;63(5):1649-64. doi: 10.2337/db13-0728. Epub 2014 Jan 29.

7.

Fast and quantitative analysis of branched-chain amino acids in biological samples using a pillar array column.

Song Y, Takatsuki K, Isokawa M, Sekiguchi T, Mizuno J, Funatsu T, Shoji S, Tsunoda M.

Anal Bioanal Chem. 2013 Oct;405(25):7993-9. doi: 10.1007/s00216-013-7034-7. Epub 2013 May 25.

PMID:
23708693
8.

Integration of pillar array columns into a gradient elution system for pressure-driven liquid chromatography.

Song Y, Noguchi M, Takatsuki K, Sekiguchi T, Mizuno J, Funatsu T, Shoji S, Tsunoda M.

Anal Chem. 2012 Jun 5;84(11):4739-45. doi: 10.1021/ac3001836. Epub 2012 May 18.

PMID:
22540342
9.

Eyeblink conditioning contingent on hippocampal theta enhances hippocampal and medial prefrontal responses.

Darling RD, Takatsuki K, Griffin AL, Berry SD.

J Neurophysiol. 2011 May;105(5):2213-24. doi: 10.1152/jn.00801.2010. Epub 2011 Feb 23.

10.

Low-dose thalidomide plus low-dose dexamethasone therapy in patients with refractory multiple myeloma.

Murakami H, Handa H, Abe M, Iida S, Ishii A, Ishikawa T, Ishida T, Oota M, Ozaki S, Kosaka M, Sakai A, Sawamura M, Shimazaki C, Shimizu K, Takagi T, Hata H, Fukuhara T, Fujii H, Miyata A, Wakayama T, Takatsuki K.

Eur J Haematol. 2007 Sep;79(3):234-9. Epub 2007 Jul 26.

PMID:
17655699
11.

Impaired motor functions in mice lacking the RNA-binding protein Hzf.

Iijima T, Ogura H, Takatsuki K, Kawahara S, Wakabayashi K, Nakayama D, Fujioka M, Kimura Y, Bernstein A, Okano HJ, Kirino Y, Okano H.

Neurosci Res. 2007 Jun;58(2):183-9. Epub 2007 Feb 28.

PMID:
17383763
12.

A simple and efficient synthesis of puromycin, 2,2'-anhydro-pyrimidine nucleosides, cytidines and 2',3'-anhydroadenosine from 3',5'-O-sulfinyl xylo-nucleosides.

Takatsuki K, Ohgushi S, Kohmoto S, Kishikawa K, Yamamoto M.

Nucleosides Nucleotides Nucleic Acids. 2006;25(7):719-34.

PMID:
16898411
13.
15.

N-methyl-D-aspartate receptors play important roles in acquisition and expression of the eyeblink conditioned response in glutamate receptor subunit delta2 mutant mice.

Kato Y, Takatsuki K, Kawahara S, Fukunaga S, Mori H, Mishina M, Kirino Y.

Neuroscience. 2005;135(4):1017-23. Epub 2005 Sep 13.

PMID:
16165299
16.

Reduced-intensity conditioning allogeneic stem cell transplantation for multiple myeloma: results from the Japan Myeloma Study Group.

Shimazaki C, Fujii H, Yoshida T, Chou T, Nishimura M, Asaoku H, Miyawaki S, Ishii A, Ishida T, Taniwaki M, Iida S, Takagi T, Takatsuki K; Japan Myeloma Study Group.

Int J Hematol. 2005 May;81(4):342-8.

PMID:
15914367
17.

Role of hippocampal NMDA receptors in trace eyeblink conditioning.

Sakamoto T, Takatsuki K, Kawahara S, Kirino Y, Niki H, Mishina M.

Brain Res. 2005 Mar 28;1039(1-2):130-6.

PMID:
15781054
18.

Discovery of adult T-cell leukemia.

Takatsuki K.

Retrovirology. 2005 Mar 2;2:16.

19.

Management of patients with multiple myeloma in Japan: data of 1,383 patients from 16 hospitals and 1 treatment group.

Shimizu K, Nagura E, Takatsuki K; Japan Myeloma Study Group.

Leuk Lymphoma. 2004 Dec;45(12):2465-9.

PMID:
15621761
20.

Humanized anti-interleukin 6 receptor antibody induced long-term remission in a patient with life-threatening refractory autoimmune hemolytic anemia.

Kunitomi A, Konaka Y, Yagita M, Nishimoto N, Kishimoto T, Takatsuki K.

Int J Hematol. 2004 Oct;80(3):246-9.

PMID:
15540899
21.

High-dose chemotherapy and autologous peripheral blood stem cell transplantation in high-risk multiple myeloma.

Murakami H, Fujii H, Inaba T, Shimazaki C, Okamoto S, Miwa A, Sawamura M, Abe M, Chou T, Asaoku H, Kitahara Y, Hayashi K, Kosaka M, Togawa A, Takatsuki K; Japan Myeloma Study Group.

Eur J Haematol. 2004 Sep;73(3):169-73.

PMID:
15287913
22.

[Thalidomide treatment of patients with refractory myeloma in the institutes participating in the Japan Myeloma Study Group].

Murakami H, Handa H, Imai K, Kanakura Y, Kosaka M, Sawamura M, Shimazaki C, Suzuki K, Ishii A, Takagi T, Taniwaki M, Togawa A, Hata H, Wakayama T, Takatsuki K; Japan Myeloma Study Group.

Rinsho Ketsueki. 2004 Jun;45(6):468-72. Japanese.

PMID:
15287523
23.

Discovery of a novel route to 2'-deoxy and 2'-functional pyrimidine nucleosides via 3',5'-O-sulfinyl xylo-nucleosides.

Takatsuki K, Kohmoto S, Kishikawa K, Yamashita H, Yamamoto M.

Nucleic Acids Res Suppl. 2002;(2):137-8.

PMID:
12903143
24.

Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109).

Tsukasaki K, Tobinai K, Shimoyama M, Kozuru M, Uike N, Yamada Y, Tomonaga M, Araki K, Kasai M, Takatsuki K, Tara M, Mikuni C, Hotta T; Lymphoma Study Group of the Japan Clinical Oncology Group.

Int J Hematol. 2003 Feb;77(2):164-70.

PMID:
12627852
25.

The hippocampus plays an important role in eyeblink conditioning with a short trace interval in glutamate receptor subunit delta 2 mutant mice.

Takatsuki K, Kawahara S, Kotani S, Fukunaga S, Mori H, Mishina M, Kirino Y.

J Neurosci. 2003 Jan 1;23(1):17-22.

26.

Time-limited role of the hippocampus in the memory for trace eyeblink conditioning in mice.

Takehara K, Kawahara S, Takatsuki K, Kirino Y.

Brain Res. 2002 Oct 4;951(2):183-90.

PMID:
12270496
27.

Hippocampal Damage Disrupts Eyeblink Conditioning in Mice Lacking Glutamate Receptor Subunit δ2.

Takatsuki K, Kawahara S, Kotani S, Mori H, Mishina M, Kirino Y.

J Biol Phys. 2002 Sep;28(3):539-47. doi: 10.1023/A:1020362000085.

28.

[Contribution of Japanese researchers to progress in the field of hematology in the last 100 years: Adult T-cell leukemia-lymphoma].

Takatsuki K.

Nihon Naika Gakkai Zasshi. 2002 Jul 10;91(7):2054-6. Japanese. No abstract available.

PMID:
12187675
29.

A comparative double-blind randomized trial of activated protein C and unfractionated heparin in the treatment of disseminated intravascular coagulation.

Aoki N, Matsuda T, Saito H, Takatsuki K, Okajima K, Takahashi H, Takamatsu J, Asakura H, Ogawa N; CTC-111-IM Clinical Research Group.

Int J Hematol. 2002 Jun;75(5):540-7.

PMID:
12095157
30.

Scopolamine impairs eyeblink conditioning in cerebellar LTD-deficient mice.

Takatsuki K, Kawahara S, Mori H, Mishina M, Kirino Y.

Neuroreport. 2002 Jan 21;13(1):159-62.

PMID:
11924880
31.

Efficacy of granulocyte colony-stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study.

Usuki K, Urabe A, Masaoka T, Ohno R, Mizoguchi H, Hamajima N, Miyazaki T, Niitsu Y, Yoshida Y, Miura A, Shibata A, Abe T, Miura Y, Ikeda Y, Nomura T, Nagao T, Saitou H, Shirakawa S, Ohkuma M, Matsuda T, Nakamura T, Horiuchi A, Kuramoto A, Kimura I, Irino S, Niho Y, Takatsuki K, Tomonaga M, Uchino H, Takaku F; Gran AML Study Group.

Br J Haematol. 2002 Jan;116(1):103-12.

PMID:
11841402
32.

Effects of the noncompetitive NMDA receptor antagonist MK-801 on classical eyeblink conditioning in mice.

Takatsuki K, Kawahara S, Takehara K, Kishimoto Y, Kirino Y.

Neuropharmacology. 2001 Oct;41(5):618-28.

PMID:
11587717
33.

A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.

Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, Tara M, Sano M, Ikeda S, Takatsuki K, Kozuru M, Araki K, Kawano F, Niimi M, Tobinai K, Hotta T, Shimoyama M.

Br J Haematol. 2001 May;113(2):375-82.

PMID:
11380402
34.

[Intravascular large B-cell lymphoma associated with hypoalbuminemia and hypoxemia].

Yagita M, Tabata R, Konaka Y, Ohno T, Takatsuki K.

Rinsho Ketsueki. 2000 Nov;41(11):1189-94. Japanese.

PMID:
11193438
35.

[Ovalbumin sensitization affects nonadrenergic noncholinergic relaxation response on guinea-pig tracheal smooth muscle].

Takatsuki K, Nishimura Y, Maeda H, Yokoyama M.

Arerugi. 2000 Jul;49(7):562-8. Japanese.

PMID:
10944822
36.

A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation.

Yagita M, Huang CL, Umehara H, Matsuo Y, Tabata R, Miyake M, Konaka Y, Takatsuki K.

Leukemia. 2000 May;14(5):922-30.

37.

Long-term remission in an elderly patient with mantle cell leukemia treated with low-dose cyclophosphamide.

Asou N, Suzushima H, Nishimura S, Okubo T, Yamasaki H, Osato M, Hoshino K, Takatsuki K, Mitsuya H.

Am J Hematol. 2000 Jan;63(1):35-7.

38.

Detection of inducible nitric oxide synthase (iNOS) mRNA by RT-PCR in ATL patients and HTLV-I infected cell lines: clinical features and apoptosis by NOS inhibitor.

Sonoki T, Matsuzaki H, Nagasaki A, Hata H, Yoshida M, Matsuoka M, Kuribayashi N, Kimura T, Harada N, Takatsuki K, Mitsuya H, Mori M.

Leukemia. 1999 May;13(5):713-8.

39.

Rapid quantification of HTLV-I provirus load: detection of monoclonal proliferation of HTLV-I-infected cells among blood donors.

Etoh K, Yamaguchi K, Tokudome S, Watanabe T, Okayama A, Stuver S, Mueller N, Takatsuki K, Matsuoka M.

Int J Cancer. 1999 Jun 11;81(6):859-64.

40.

[Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia/lymphoma].

Arima N, Mizoguchi H, Shirakawa S, Tomonaga M, Takatsuki K, Ohno R.

Gan To Kagaku Ryoho. 1999 Apr;26(5):619-29. Japanese.

PMID:
10234292
41.

Characterization of T-cell receptor beta chain mRNA expression in IFN-alpha-responsive chronic myelogenous leukaemia patients.

Shimomura T, Fujii S, Ezaki I, Osato M, Fujimoto K, Takatsuki K, Yamamoto K, Kawakita M.

Br J Haematol. 1999 Apr;105(1):173-80.

PMID:
10233381
43.

Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias.

Osato M, Asou N, Abdalla E, Hoshino K, Yamasaki H, Okubo T, Suzushima H, Takatsuki K, Kanno T, Shigesada K, Ito Y.

Blood. 1999 Mar 15;93(6):1817-24.

PMID:
10068652
44.

Establishment of a monoclonal antibody to human myeloma cell: relation to chemotherapy and extramedullar infiltration.

Kuribayashi N, Hata H, Matsuzaki H, Yoshida M, Sonoki T, Nagasaki A, Kimura T, Harada N, Takatsuki K.

Med Oncol. 1998 Dec;15(4):248-54.

PMID:
9951688
45.

Induction of antitumor cytotoxic activity using CD34+ cord blood cell-derived and irradiated tumor cell-primed dendritic cells.

Fujii S, Fujimoto K, Osato M, Matsui K, Takatsuki K, Kawakita M.

Int J Hematol. 1998 Aug;68(2):169-82.

PMID:
9803675
46.

Acute myelomonoblastic leukemia carrying the PEBP2beta/MYH11 fusion gene.

Asou N, Osato M, Okubo T, Yamasaki H, Hoshino K, Nishimura S, Era T, Suzushima H, Takatsuki K.

Leuk Lymphoma. 1998 Sep;31(1-2):81-91. Review.

PMID:
9720717
47.

Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells.

Tamiya S, Etoh K, Suzushima H, Takatsuki K, Matsuoka M.

Blood. 1998 May 15;91(10):3935-42.

PMID:
9573032
48.

Characterization of mRNA expression of IkappaB alpha and NF-kappaB subfamilies in primary adult T-cell leukemia cells.

Inoue M, Matsuoka M, Yamaguchi K, Takatsuki K, Yoshida M.

Jpn J Cancer Res. 1998 Jan;89(1):53-9.

49.

[Psychiatric studies of chemotherapy and chemotherapy-induced nausea and vomiting of patients with lung or thymic cancer].

Takatsuki K, Kado T, Satouchi M, Nakajima T, Nagai K, Ohsugi F, Yanagida E, Minegaki A.

Gan To Kagaku Ryoho. 1998 Feb;25(3):403-8. Japanese.

PMID:
9492835
50.

Markedly high plasma erythropoietin and granulocyte-colony stimulating factor levels in patients with paroxysmal nocturnal hemoglobinuria.

Nakakuma H, Nagakura S, Kawaguchi T, Horikawa K, Iwamoto N, Kagimoto T, Takatsuki K.

Int J Hematol. 1997 Dec;66(4):451-7.

PMID:
9479872

Supplemental Content

Loading ...
Support Center